Who invested in Treeline Biosciences?
Treeline Biosciences's investors include OrbiMed, Fidelity and ARCH Venture Partners.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$200Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $200M sold, first sale Aug 2025
Treeline Biosciences's investors include OrbiMed, Fidelity and ARCH Venture Partners.
Treeline Biosciences has raised $200M across 1 round since 2025.
Treeline Biosciences's most recent round was a Series A of $200M in Sept 2025.
Its most recent round, $200M in Sept 2025, is also its largest on record.
Treeline Biosciences's first round on record, in Sept 2025, was backed by OrbiMed, Fidelity and ARCH Venture Partners.
Treeline Biosciences's latest named round is a Series A, in Sept 2025.
Treeline Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.